A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis

  • Sharma, Niyati (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date15/07/20 → 14/07/25
View all
View less

Keywords

  • clinical trial
  • atopic dermatitis
  • treatment efficacy
  • treatment safety